Parawixin2 Protects Hippocampal Cells in Experimental Temporal Lobe Epilepsy

Epilepsy is considered as one of the major disabling neuropathologies. Almost one third of adult patients with temporal lobe epilepsy (TLE) do not respond to current antiepileptic drugs (AEDs). Additionally, most AEDs do not have neuroprotective effects against the inherent neurodegenerative process...

Full description

Bibliographic Details
Main Authors: José Luiz Liberato, Lívea Dornela Godoy, Alexandra Olimpio Siqueira Cunha, Marcia Renata Mortari, Rene de Oliveira Beleboni, Andréia C. K. Fontana, Norberto Peporine Lopes, Wagner Ferreira dos Santos
Format: Article
Language:English
Published: MDPI AG 2018-11-01
Series:Toxins
Subjects:
Online Access:https://www.mdpi.com/2072-6651/10/12/486
_version_ 1798040974830600192
author José Luiz Liberato
Lívea Dornela Godoy
Alexandra Olimpio Siqueira Cunha
Marcia Renata Mortari
Rene de Oliveira Beleboni
Andréia C. K. Fontana
Norberto Peporine Lopes
Wagner Ferreira dos Santos
author_facet José Luiz Liberato
Lívea Dornela Godoy
Alexandra Olimpio Siqueira Cunha
Marcia Renata Mortari
Rene de Oliveira Beleboni
Andréia C. K. Fontana
Norberto Peporine Lopes
Wagner Ferreira dos Santos
author_sort José Luiz Liberato
collection DOAJ
description Epilepsy is considered as one of the major disabling neuropathologies. Almost one third of adult patients with temporal lobe epilepsy (TLE) do not respond to current antiepileptic drugs (AEDs). Additionally, most AEDs do not have neuroprotective effects against the inherent neurodegenerative process underlying the hippocampal sclerosis on TLE. Dysfunctions in the GABAergic neurotransmission may contribute not only to the onset of epileptic activity but also constitute an important system for therapeutic approaches. Therefore, molecules that enhance GABA inhibitory effects could open novel avenues for the understanding of epileptic plasticity and for drug development. Parawixin2, a compound isolated from <i>Parawixia bistriata</i> spider venom, inhibits both GABA and glycine uptake and has an anticonvulsant effect against a wide range of chemoconvulsants. The neuroprotective potential of Parawixin2 was analyzed in a model of TLE induced by a long-lasting Status Epilepticus (SE), and its efficiency was compared to well-known neuroprotective drugs, such as riluzole and nipecotic acid. Neuroprotection was assessed through histological markers for cell density (Nissl), astrocytic reactivity (GFAP) and cell death labeling (TUNEL), which were performed 24 h and 72 h after SE. Parawixin2 treatment resulted in neuroprotective effects in a dose dependent manner at 24 h and 72 h after SE, as well as reduced reactive astrocytes and apoptotic cell death. Based on these findings, Parawixin2 has a great potential to be used as a tool for neuroscience research and as a probe to the development of novel GABAergic neuroprotective agents.
first_indexed 2024-04-11T22:15:04Z
format Article
id doaj.art-fdd5ed9d2e434e1ca3bc74f07c98105a
institution Directory Open Access Journal
issn 2072-6651
language English
last_indexed 2024-04-11T22:15:04Z
publishDate 2018-11-01
publisher MDPI AG
record_format Article
series Toxins
spelling doaj.art-fdd5ed9d2e434e1ca3bc74f07c98105a2022-12-22T04:00:27ZengMDPI AGToxins2072-66512018-11-01101248610.3390/toxins10120486toxins10120486Parawixin2 Protects Hippocampal Cells in Experimental Temporal Lobe EpilepsyJosé Luiz Liberato0Lívea Dornela Godoy1Alexandra Olimpio Siqueira Cunha2Marcia Renata Mortari3Rene de Oliveira Beleboni4Andréia C. K. Fontana5Norberto Peporine Lopes6Wagner Ferreira dos Santos7Neurobiology and Venoms Laboratory (LNP), Department of Biology, College of Philosophy, Sciences and Literature of Ribeirão Preto, University of São Paulo, Av. Bandeirantes, 3900, Ribeirão Preto, 14040-901 São Paulo, BrazilNeurobiology and Venoms Laboratory (LNP), Department of Biology, College of Philosophy, Sciences and Literature of Ribeirão Preto, University of São Paulo, Av. Bandeirantes, 3900, Ribeirão Preto, 14040-901 São Paulo, BrazilNeurobiology and Venoms Laboratory (LNP), Department of Biology, College of Philosophy, Sciences and Literature of Ribeirão Preto, University of São Paulo, Av. Bandeirantes, 3900, Ribeirão Preto, 14040-901 São Paulo, BrazilLaboratory of Neuropharmacology, Department of Physiological Sciences, Institute of Biological Sciences, University of Brasília, DF 70910-900 Brasília, BrazilDepartment of Biotechnology/School of Medicine, University of Ribeirão Preto, Av. Costábile Romano, 2201, Ribeirão Preto, 14096-900 São Paulo, BrazilDepartment of Pharmacology and Physiology, Drexel University College of Medicine, 245 N. 15th Street, Philadelphia, PA 19102, USANPPNS, Department of Physics and Chemistry, College of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil, Av. do Cafe s/n, Ribeirão Preto, 14040-903 São Paulo, BrazilNeurobiology and Venoms Laboratory (LNP), Department of Biology, College of Philosophy, Sciences and Literature of Ribeirão Preto, University of São Paulo, Av. Bandeirantes, 3900, Ribeirão Preto, 14040-901 São Paulo, BrazilEpilepsy is considered as one of the major disabling neuropathologies. Almost one third of adult patients with temporal lobe epilepsy (TLE) do not respond to current antiepileptic drugs (AEDs). Additionally, most AEDs do not have neuroprotective effects against the inherent neurodegenerative process underlying the hippocampal sclerosis on TLE. Dysfunctions in the GABAergic neurotransmission may contribute not only to the onset of epileptic activity but also constitute an important system for therapeutic approaches. Therefore, molecules that enhance GABA inhibitory effects could open novel avenues for the understanding of epileptic plasticity and for drug development. Parawixin2, a compound isolated from <i>Parawixia bistriata</i> spider venom, inhibits both GABA and glycine uptake and has an anticonvulsant effect against a wide range of chemoconvulsants. The neuroprotective potential of Parawixin2 was analyzed in a model of TLE induced by a long-lasting Status Epilepticus (SE), and its efficiency was compared to well-known neuroprotective drugs, such as riluzole and nipecotic acid. Neuroprotection was assessed through histological markers for cell density (Nissl), astrocytic reactivity (GFAP) and cell death labeling (TUNEL), which were performed 24 h and 72 h after SE. Parawixin2 treatment resulted in neuroprotective effects in a dose dependent manner at 24 h and 72 h after SE, as well as reduced reactive astrocytes and apoptotic cell death. Based on these findings, Parawixin2 has a great potential to be used as a tool for neuroscience research and as a probe to the development of novel GABAergic neuroprotective agents.https://www.mdpi.com/2072-6651/10/12/486spider toxin<i>Parawixia bistriata</i>Parawixin2GABA uptake inhibitortemporal lobe epilepsypilocarpine modelhippocampal lost cellsneuroprotection
spellingShingle José Luiz Liberato
Lívea Dornela Godoy
Alexandra Olimpio Siqueira Cunha
Marcia Renata Mortari
Rene de Oliveira Beleboni
Andréia C. K. Fontana
Norberto Peporine Lopes
Wagner Ferreira dos Santos
Parawixin2 Protects Hippocampal Cells in Experimental Temporal Lobe Epilepsy
Toxins
spider toxin
<i>Parawixia bistriata</i>
Parawixin2
GABA uptake inhibitor
temporal lobe epilepsy
pilocarpine model
hippocampal lost cells
neuroprotection
title Parawixin2 Protects Hippocampal Cells in Experimental Temporal Lobe Epilepsy
title_full Parawixin2 Protects Hippocampal Cells in Experimental Temporal Lobe Epilepsy
title_fullStr Parawixin2 Protects Hippocampal Cells in Experimental Temporal Lobe Epilepsy
title_full_unstemmed Parawixin2 Protects Hippocampal Cells in Experimental Temporal Lobe Epilepsy
title_short Parawixin2 Protects Hippocampal Cells in Experimental Temporal Lobe Epilepsy
title_sort parawixin2 protects hippocampal cells in experimental temporal lobe epilepsy
topic spider toxin
<i>Parawixia bistriata</i>
Parawixin2
GABA uptake inhibitor
temporal lobe epilepsy
pilocarpine model
hippocampal lost cells
neuroprotection
url https://www.mdpi.com/2072-6651/10/12/486
work_keys_str_mv AT joseluizliberato parawixin2protectshippocampalcellsinexperimentaltemporallobeepilepsy
AT liveadornelagodoy parawixin2protectshippocampalcellsinexperimentaltemporallobeepilepsy
AT alexandraolimpiosiqueiracunha parawixin2protectshippocampalcellsinexperimentaltemporallobeepilepsy
AT marciarenatamortari parawixin2protectshippocampalcellsinexperimentaltemporallobeepilepsy
AT renedeoliveirabeleboni parawixin2protectshippocampalcellsinexperimentaltemporallobeepilepsy
AT andreiackfontana parawixin2protectshippocampalcellsinexperimentaltemporallobeepilepsy
AT norbertopeporinelopes parawixin2protectshippocampalcellsinexperimentaltemporallobeepilepsy
AT wagnerferreiradossantos parawixin2protectshippocampalcellsinexperimentaltemporallobeepilepsy